Clincosm LogoSign in Get a demo

Urothelial Cancer

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)

Recruiting
  • Urothelial Cancer
  • Nivolumab
  • +4 more
  • Birmingham, Alabama
  • +196 more
Jan 17, 2023

Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)

Active, not recruiting
Has Results
  • Urothelial Cancer
  • MEDI4736 (Durvalumab)
  • +4 more
  • Los Angeles, California
  • +221 more
Nov 2, 2022

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab 800 mg in combination with pemetrexed / carboplatin
  • +3 more
  • Tucson, Arizona
  • +45 more
Oct 13, 2022

Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

Recruiting
  • Urothelial Cancer
  • Anchorage, Alaska
  • +414 more
Jul 14, 2022

Urothelial Cancer Trial in Italy (Pemigatinib)

Active, not recruiting
  • Urothelial Cancer
  • Bergamo, Italy
  • +4 more
Jan 25, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022